W. Thomas Purcell

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Cecal Volvulus as a Rare Complication of Osimertinib Dosed at 160 mg in Patients With EGFR-Mutant Non-small Cell Lung Cancer”.

Cecal Volvulus as a Rare Complication of Osimertinib Dosed at 160 mg in Patients With EGFR-Mutant Non-small Cell Lung Cancer

Frontiers in Oncology(2020)10.3389/fonc.2020.00510

N/A

0DataRank · unranked

3 citations

Jose M. Pacheco, Anastasios Dimou, W. Thomas Purcell, Candice Rossi, Paul A. Bunn +4 more

Results from the safety lead-in for a phase II study of pembrolizumab in combination with binimetinib and bevacizumab in patients with refractory metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4031

N/A

0DataRank · unranked

8 citations

S. Lindsey Davis, Stephen Leong, Alexis D. Leal, Patrick J. Blatchford, Gurprataap Singh Sandhu +15 more

Impact of Radiation Dose on Postoperative Complications in Esophageal and Gastroesophageal Junction Cancers

Frontiers in Oncology(2021)10.3389/fonc.2021.614640

N/A

0DataRank · unranked

9 citations

Megan Marsh, Martin D. McCarter, Robert A. Meguid, Narine Wandrey Bhardwaj, John D. Mitchell +17 more